It appears astonishing to me that this company is making
such claims as to the effectivity of Silver Colloid.......against
malaria. If true, it is the first successful protocol involving
CS, of which I am aware.
The type, size and scope of their actual studies, plus the dynamics
of the actual protocol application would be most
enlightening......providing they do in fact exist. This should be
international headline stuff.....if genuine.
All of our research on malarial plasmodiums.....involving direct
address by CS, IN VIVO, has proven futile.
This is not to say that others have not found success in their
attempts......but the very nature of the malarial agent seems to
present a VERY profound challenge for nominal levels of CS.
References to peer reviews or copies of actual research results
achieved by this company (exclusive of any proprietary product
manufacturing procedures) would be greatly appreciated......from
anyone on this list, cognizant of such. Sincerely, Brooks
Bradley.
----- Original Message -----
From: tornado <1a...@xs4all.nl>
To: silver-list@eskimo.com
Subject: CS> Clifton Mining/Malaria News
Date: Sun, 22 May 2005 13:09:06 +0200
>
> Committee on International Relations U.S. House of Representatives
> Henry J. Hyde, Chairman
> CONTACT: Sam Stratman, (202) 226-7875, March 16, 2005
>
> For IMMEDIATE Release
>
> Combating Malaria and Tuberculosis
> Christopher Smith Schedules Tuesday Hearing on Implementing
> Proven Treatment and Eradication Methods
> BACKGROUND: The global pandemic of HIV/AIDS is frequently the
> focus of high-profile news coverage, but much of the developing
> world is being ravaged by two other, relatively unknown, killer
> diseases: malaria and tuberculosis (TB). One-third of the world
> is infected with the TB bacterium, and it is the leading cause of
> death for people with HIV/AIDS. Africa is currently experiencing
> a TB explosion due in large part to the AIDS pandemic. Similarly,
> Malaria is the primary killer of children and pregnant women in
> Africa, and one of the top killers in Asia and South America.
> Every day about 3,000 children die from the disease worldwide.
> Infection rates for malaria dwarf those of HIV/AIDS, and the vast
> majority of malaria patients are pregnant women and children
> living in poverty. However, both diseases are preventable and
> curable. A six-month course of anti-TB drugs costs only $12 and
> can produce cure rates of up to 95 percent even in the poorest
> countries. Malaria, likewise, is inexpensive and easy to treat,
> and can be controlled with proven successful methods combining
> anti-malarial drugs, bed nets, and use of small, environmentally
> safe amounts of insecticide in homes and buildings. In FY 2005,
> the United States will provide $2.9 billion in bilateral and
> multilateral assistance to fight HIV/AIDS, malaria and
> tuberculosis. Among the witnesses scheduled to testify Tuesday is
> Youssou N?Dour, Senegalese Jazz Musician, Goodwill Ambassador,
> and Roll Back Malaria Partnership.
>
> WHAT: Subcommittee Oversight Hearing: Malaria and TB:
> Implementing Proven Treatment
> and Eradication Methods
> Subcommittee on Africa, Global Human Rights and International Operations,
> U.S. Rep. Christopher H. Smith (R-NJ), Chairman
> WHEN: 2:00 p.m., Tuesday, April 26, 2005
> WHERE: Room 2172 Rayburn House Office Building
>
> WITNESSES: Mark Dybul, M.D., Assistant U.S. Global AIDS
> Coordinator and Chief Medical Officer, Office of the
> U.S. Global AIDS Coordinator, U.S. Department of State;
>
> Michael Miller, Deputy Assistant Administrator, Bureau for Global
> Health, U.S. Agency for
> International Development;
>
> William Moeller, President and CEO, American Biotech Labs;
>
> Youssou N?Dour, Senegalese Jazz Musician, Goodwill Ambassador,
> Roll Back Malaria Partnership; and
>
> Paul Nunn, M.D., Coordinator, TB, HIV, and Drug Resistance Unit,
> World Health Organization.
>
> http://wwwc.house.gov/international_relations/109/news042605 .htm
> Written Testimony of William D. Moeller
> President, American Biotech Laboratories
> 80 West Canyon Crest Road
> Alpine, Utah 84004
> Presented to Members of The House International Relations Committee
> Subcommittee on Africa, Global Human Rights, and International Operations
> April 26, 2005
> INTRODUCTION
> Good Morning. I am William D. Moeller, Chairman and President of
> American Biotech Laboratories
> of Alpine, Utah (ABL), a company which produces engineered,
> metallic silver, nano-sized particles
> in water-based products. Our engineered silver particles have
> performed far beyond anyones
> expectations as anti-microbial agents, against a staggering
> variety of microbes such as malaria, flesheating
> bacteria (MRSA Methicillin Resistant Staphylococcus aureus) and E.coli.
> Whether used on surfaces as disinfectants or if taken internally
> as supplements, all of our ABL products
> are non-toxic and have no known adverse human side effects. Our
> products have surprised many
> experts in the medical and science worlds because of their
> ability to combat bacteria, yeast, and viruses.
> ABL products have been proven to destroy anthrax spores and
> bubonic plague bacteria on surfaces, to
> eliminate the malaria parasite in humans and a host of other
> beneficial results.
> We have developed five products to date as well as several other
> new products currently in our product
> development pipeline. We manufacture all of our products in the
> United States. One product ASAPAGX-
> 32 (a water solution containing 32 ppm of our engineered silver
> nano-particles) has already been
> approved by the EPA as a surface disinfectant for hard,
> non-porous surfaces in commercial, residential,
> industrial, hospital and medical environments. Another product
> called Silgel is a non-toxic
> moisturizing gel, which utilizes our ASAP-AGX-32 as a raw
> material supply of silver particles. It is
> currently undergoing the final steps for FDA approval for the
> treatment of lacerations, first and second
> degree burns, abrasions, surgical wounds, skin ulcers etc.
> Several other new ABL products will soon
> warrant the filing of new FDA and/or USDA applications.
> More.....
>
> http://wwwc.house.gov/international_relations/109/moe042605. pdf
>
>
>
>
>
> --
> The Silver List is a moderated forum for discussing Colloidal Silver.
>
> Instructions for unsubscribing are posted at: http://silverlist.org
>
> To post, address your message to: silver-list@eskimo.com
> Silver List archive: http://escribe.com/health/thesilverlist/index.html
>
> Address Off-Topic messages to: silver-off-topic-l...@eskimo.com
> OT Archive: http://escribe.com/health/silverofftopiclist/index.html
>
> List maintainer: Mike Devour <mdev...@eskimo.com>
--
_______________________________________________
NEW! Lycos Dating Search. The only place to search multiple dating sites at
once.
http://datingsearch.lycos.com
